Sagimet Biosciences (SGMT) Current Assets (2023 - 2024)
Sagimet Biosciences has reported Current Assets over the past 2 years, most recently at $157.2 million for Q3 2024.
- Quarterly results put Current Assets at $157.2 million for Q3 2024, up 52.88% from a year ago — trailing twelve months through Sep 2024 was $157.2 million (up 52.88% YoY), and the annual figure for FY2023 was $96.6 million, changed.
- Current Assets for Q3 2024 was $157.2 million at Sagimet Biosciences, down from $166.8 million in the prior quarter.
- Over the last five years, Current Assets for SGMT hit a ceiling of $194.5 million in Q1 2024 and a floor of $21.4 million in Q2 2023.